Otsuka Pharmaceutical Co., Ltd.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25364
 
  
 
C07D HETEROCYCLIC COMPOUNDS 10866
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 34133
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 30176
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2871
 
  
 
C07K PEPTIDES 21115
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2075
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1534
 
  
 
0901 BOTTLES, FLASKS, POTS, CARBOYS, DEMIJOHNS, AND CONTAINERS WITH DYNAMIC DISPENSING MEANS1542
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13112

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0073,020 SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAMEAug 21, 17Mar 15, 18[C12N]
2018/0055,840 ORAL FORMULATIONOct 27, 17Mar 01, 18[A61K]
2018/0055,941 INJECTABLE PREPARATIONSep 11, 17Mar 01, 18[A61K]
2018/0042,923 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDEROct 19, 17Feb 15, 18[A61K]
2018/0032,673 PATHOLOGY DETERMINATION ASSISTANCE DEVICE, METHOD AND STORAGE MEDIUMSep 03, 14Feb 01, 18[G06F]
2018/0008,599 PHARMACEUTICAL PREPARATION COMPRISING BREXPIPRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRINSep 22, 17Jan 11, 18[A61K, B82Y]
2018/0003,695 METHOD FOR QUANTITATIVE MEASUREMENT OF GASTRIC ACIDITY USING 13C CARBONATE SALTSep 15, 17Jan 04, 18[A61K, C12Q, G01N, A61B]
2017/0258,723 ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLE AND METHOD FOR PRODUCING ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLEMay 22, 17Sep 14, 17[A61J, A61K]
2017/0239,265 DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASEMay 05, 17Aug 24, 17[A61K]
2017/0216,260 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITIONApr 11, 17Aug 03, 17[A61K, C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9851356 Method for measuring anti-WT1 antibodySep 13, 12Dec 26, 17[A61K, G01N, C07K]
9839637 Piperazine-substituted benzothiophenes for treatment of mental disordersSep 06, 17Dec 12, 17[A61K, C07D]
9833493 Method for activating helper T cellDec 16, 13Dec 05, 17[A61K, C12N, C07K]
9834576 Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridinesOct 29, 14Dec 05, 17[C07H, C07B]
9809609 Water-soluble benzoazepine compound and its pharmaceutical compositionMay 01, 12Nov 07, 17[A61K, C07F, A61P]
9763935 Controlled release sterile injectable aripiprazole formulation and methodOct 06, 14Sep 19, 17[A61K]
9750694 Transpulmonary liposome for controlling drug arrivalDec 17, 13Sep 05, 17[A61K, C12N]
9707729 Method and apparatus for manufacturing nucleated tabletsJun 12, 14Jul 18, 17[A61J, A61K, A61B, B30B]
9708292 Cyanopyrimidine derivativeFeb 02, 10Jul 18, 17[A61K, C07D]
9694009 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersJun 08, 16Jul 04, 17[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0231,983 Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersAbandonedMay 02, 17Aug 17, 17[A61K]
2017/0217,923 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USEAbandonedMar 13, 17Aug 03, 17[C07D]
2017/0202,833 ORAL FORMULATIONAbandonedApr 05, 17Jul 20, 17[A61K]
2017/0165,258 TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOFAbandonedFeb 27, 17Jun 15, 17[A61K]
2017/0151,237 PHARMACEUTICAL PREPARATION COMPRISING BREXPIPRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRINAbandonedFeb 10, 17Jun 01, 17[A61K]
2017/0137,902 NOVEL LACTOBACILLUS PARACASEI STRAINAbandonedMar 23, 15May 18, 17[C12R, A61K, A23L, C12N]
2017/0100,395 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDERAbandonedDec 21, 16Apr 13, 17[A61K]
2017/0071,933 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTSAbandonedNov 23, 16Mar 16, 17[A61K]
2017/0000,786 Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersAbandonedSep 15, 16Jan 05, 17[A61K]
2016/0324,737 EMULSION COMPOSITION FOR SKINAbandonedAug 04, 14Nov 10, 16[A61K, A61Q]
2016/0310,617 PHARMACEUTICAL PREPARATION COMPRISING BREXPIPRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRINAbandonedApr 08, 16Oct 27, 16[A61K]
2016/0304,461 QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITIONAbandonedJun 27, 16Oct 20, 16[C07D]
2016/0251,315 LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCE3SSES FOR THE PREPARATION THEREOFAbandonedMay 09, 16Sep 01, 16[C07D]
2016/0158,227 TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY)-1H-QUINOLIN-2-ONE OR A SALT THEREOFAbandonedFeb 09, 16Jun 09, 16[A61K]
2016/0008,434 STEM CELL FOR THERAPEUTIC USE WHICH IS DERIVED FROM HUMAN MONOCYTE, AND METHOD FOR INDUCING SAMEAbandonedSep 24, 15Jan 14, 16[A61K]
2015/0374,730 CHOLESTANOL DERIVATIVE FOR COMBINED USEAbandonedSep 03, 15Dec 31, 15[A61K]
2015/0352,095 Tetomilast PolymorphsAbandonedAug 19, 15Dec 10, 15[A61K]
2015/0297,694 CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLSAbandonedSep 03, 13Oct 22, 15[A61K, C12N, G01N]
2015/0272,946 Prophylactic and/or Therapeutic Agent for Behavioral And Psychological Symptoms Associated With Neurodegenerative Disease or Impulsive Symptoms Associated With Mental Disease Containing Brexpiprazole or Salt ThereofAbandonedOct 24, 13Oct 01, 15[A61K]
2015/0246,032 PHARMACEUTICAL COMPOSITION COMPRISING REBAMIPIDEAbandonedSep 27, 13Sep 03, 15[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.